Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Profound Medical (PROF) Shares Outstanding (Diluted Average) (2023 - 2026)

Profound Medical has reported Shares Outstanding (Diluted Average) over the past 3 years, most recently at $30.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 22.08% year-over-year to $30.2 million; the TTM value through Dec 2025 reached $30.2 million, up 22.08%, while the annual FY2025 figure was $30.2 million, 22.08% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $30.2 million at Profound Medical, roughly flat from $30.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $30.2 million in Q4 2025 and troughed at $2.0 million in Q1 2024.
  • A 3-year average of $21.3 million and a median of $27.4 million in 2024 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): rose 16.91% in 2024 and later soared 1384.84% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $21.2 million in 2023, then rose by 16.91% to $24.8 million in 2024, then rose by 22.08% to $30.2 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for PROF at $30.2 million in Q4 2025, $30.1 million in Q3 2025, and $30.1 million in Q2 2025.